Navigation Links
LF Elimination Program Treats Over Half Billion People and Protects Millions More From Debilitating Disease
Date:10/7/2008

te Lymphatic Filariasis began in 1997 when the World Health Assembly unanimously resolved to eliminate the disease globally as a public health problem. In 1998, two pharmaceutical companies -- GlaxoSmithKline (then SmithKline Beecham) and Merck & Co., Inc. -- partnered with WHO and pledged to donate two of the drugs necessary for LF elimination (albendazole and Mectizan(R), respectively) to treat as many people as necessary for as long as required, an unprecedented donation to global public health. This partnership along with others from the public and private sector evolved into the Global Alliance to Eliminate LF. This Alliance is a free and unrestricted partnership of interested groups with the LF endemic countries at the core with the objective of advocating for LF elimination and working towards resource mobilization.

Media Availability:

Professor David Molyneux, Executive Secretary of the Global Alliance to Eliminate Lymphatic Filariasis; Dr. Mwele Malecela, Chair of the Global Alliance to Eliminate Lymphatic Filariasis and Director of the Tanzania National LF elimination program; Dr. Eric Ottesen, Director of the Atlanta Lymphatic Filariasis Support Center, and Dr. Lorenzo Savioli, Director, WHO Department of Neglected Tropical Diseases are available for media interviews. B-roll is available for television producers; photo images and a map of LF endemic countries and regions are available for all at http://www.filariasis.org.

GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit http://www.gsk.com.


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Zimmer Holdings Announces Support for Elimination of Super-Majority Voting Requirements
2. Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program
3. Pharmaxis Research Programs Highlighted at European Respiratory Society Congress
4. Stem Cell Transplantation Program at Hackensack University Medical Center: First in Nation to Receive Joint Commission Certification for Quality and First in New Jersey to be Named a Blue Distinction(R) Center for Specialty Care.
5. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
6. AEterna Zentaris Completes Patient Recruitment for Second Efficacy Trial of its Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
7. UCB Scholarship Program Awards $300,000 to Students Living with Crohns Disease
8. PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program
9. KGI Offers Mammalian Cell Culture Program for Biotech Industry Professionals
10. Trillium secures additional financing on the strength of lead program and proprietary position around the CD200 immunoregulatory pathway
11. Microchip Biotechnologies, Inc. Awarded Contract Under US Army Commercialization Pilot Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... 2015 , ... It is now possible to separate two common disorders: post-traumatic ... tomography (SPECT) according to researchers from Amen Clinics, UCLA, Thomas Jefferson University, and ... is believed to be the largest brain imaging study ever, will be published on ...
(Date:7/1/2015)... , July 1, 2015   Neuraltus Pharmaceuticals, ... development of groundbreaking drugs to treat neurodegenerative diseases ... that Robert G. Miller , M.D., Director of ... Health,s California Pacific Medical Center in San Francisco, has ... for $1.5 million to help fund a Phase ...
(Date:7/1/2015)... , ... July 01, 2015 , ... Apex Therapeutics announced ... International Convention in Philadelphia, PA. , The presentation took place on Tuesday, ... the plans for the development of APX3330 for the treatment of pancreatic cancer. ...
(Date:6/30/2015)... CALGARY , June 30, 2015 /PRNewswire/ - ... ("Shareholders") of common shares of Resverlogix have approved ... to Eastern Capital Limited of 5,600,000 units at ... Private Placement"), each unit being comprised of one ... for aggregate proceeds of approximately CAD$15 million; and ...
Breaking Biology Technology:Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3
... Library of Life Science Research and Enables Experiment ... SIAL ) and Ingenuity Systems today ... Web-based biological search portal for exploring dynamic gene-based ... extensive library of research findings, Your Favorite Gene ...
... Development of Accurate Blood Test for Common Genetic Disorders ... Artemis Health Inc., a privately-held company dedicated to the ... it has acquired a co-exclusive worldwide license from ... diagnostic tests based on pioneering research from the lab ...
... Australia, Jan. 27 /PRNewswire-Asia/ -- Pharmaxis Ltd (AXS: PXS,Nasdaq: ... Quarterly Report to Shareholders,on the afternoon of Wednesday, 28th ... teleconference the following morning to review the quarter,and answer ... will be on Thursday, 29th January at 8:30am (Sydney),(Wednesday, ...
Cached Biology Technology:Sigma-Aldrich Launches Your Favorite Gene Powered by Ingenuity 2Sigma-Aldrich Launches Your Favorite Gene Powered by Ingenuity 3Sigma-Aldrich Launches Your Favorite Gene Powered by Ingenuity 4Artemis Health Licenses Prenatal Cell-Free DNA Analysis Technology from Stanford University 2Artemis Health Licenses Prenatal Cell-Free DNA Analysis Technology from Stanford University 3
(Date:6/17/2015)... BEACH GARDENS, Fla. , June 17, 2015 ... management solutions, today announced that its U.are.U ® ... Togo,s Eateries, Inc., a ... fast casual sandwich chain, to increase security, improve ... Crossmatch fingerprint readers enable instant, non-repudiable identity confirmation ...
(Date:6/16/2015)... 2015 Fingerprint Cards has received an ... the company,s portfolio from one of its module partners in ... take place during the third quarter 2015. The sensors will ... . Jörgen Lantto, CEO of FPC, comments: " ... growing interest from smartphone OEMs in integrating touch fingerprint sensors ...
(Date:6/15/2015)... A new report [ 1 ] ... consumers using mobile banking applications want their mobile devices to ... instead of having to prove who they are with passwords ...   -   The Fusion of Financial Services, Mobile and ... channel used by Gen X and Gen Y to access ...
Breaking Biology News(10 mins):Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 4
... diet high in red meat, fatty products, refined grains, ... be increasing their chance of disease relapse and early ... study, published in the Aug. 15 issue of the ... with stage III colon cancer that has been treated ...
... show it is overwhelmingly likely that life began ... scientists. Professor Chandra Wickramasinghe and colleagues at ... case for panspermia - the theory that life ... across the galaxy. A recent BBC Horizon documentary ...
... torrents of microscopic waves propel white blood cells toward ... holds the potential for better understanding and treatment of ... very high-resolution light microscope, the dynamic waves are made ... protein and a second key player were already known ...
Cached Biology News:'Western' diet linked to increased risk of colon cancer recurrence 2Bursts of waves drive immune system 'soldiers' toward invaders 2Bursts of waves drive immune system 'soldiers' toward invaders 3Bursts of waves drive immune system 'soldiers' toward invaders 4
Goat polyclonal to Glucose Dehydrogenase ( Abpromise for all tested applications). Antigen: Glucose Dehydrogenase (Bacillus species)...
Phospho-CD18 (Ser756/Thr758/759) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Rabbit polyclonal to pCrosstide (HRP) ( Abpromise for all tested applications)....
Acetyl-Histone H2B (Lys20) Antibody...
Biology Products: